Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Most commercial insurance plans require prior authorization and may not cover weight management indications, leaving patients responsible for substantial out-of-pocket costs
GLP-1: glucagon-like peptide 1 receptor
AOD-9604 (Fragment 176-191) is a synthetic peptide derived from the C-terminal region of human growth hormone, investigated in lipolysis and lipid-metabolism research models
Officials at the Food and Drug Administration (FDA) have issued Foundayo was approved for use in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain long-term weight reduction in adults with obesity or overweight with at least one weight-related comorbid condition
